�鶹��

Dr Prue took part in a global research trial that reviewed the effects of high intensity exercise on the progression of prostate cancer and treatment side effects.

A local study took place in Northern Ireland to research the feasibility of exercise programmes for patients unable to perform high-intensity exercise.

This was the first study of its kind among men with advanced prostate cancer. It reviewed the possibility and efficacy of physical activity and set the benchmark for patients suffering from other forms of cancer.

The study has been extended to research the effects of exercise on patients with pancreatic cancer. 

Patients took part in a 16-week progressive exercise programme while receiving chemotherapy. The research assessed the feasibility of the programme, including recruitment and retention rates. It also focused on the safety of the patients.

The study reviewed changes in fitness and patient-reported outcomes at the beginning, end and three months after the intervention.

Dr Prue and her team have since started researching how exercise can impact those suffering from colorectal cancer. The study tailors supervised physical activity and nutritional counselling interventions to patients.

Dr Prue aims to improve access to exercise programmes beyond clinical trials. Her research explores methods to improve participation and adherence to exercise among individuals diagnosed with ovarian cancer.

In addition, there is a brand-new project that reviews the effect of exercise among people diagnosed with lung cancer.

Acute Myeloid Leukaemia (AML) treatment involves several rounds of intense chemotherapy. This treatment often causes fatigue and has a negative impact on emotional wellbeing and quality of life.

Prehabilitation programmes incorporate exercise, nutrition and psychological wellbeing to support patients undergoing AML treatment. Dr Prue is researching the feasibility and cost-effectiveness of these programmes.